Cargando…

Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair

BACKGROUND: Due to oral nano-delivery systems for the treatment of inflammatory bowel disease (IBD) are often failed to accumulated to the colonic site and could not achieve controlled drug release, it’s urgent to develop a microenvironment responsive drug delivery to improve therapy efficacy. Infla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Fenting, Zeng, Fancai, Yu, Xin, Deng, Yiping, Zhang, Zongquan, Xu, Maochang, Ding, Nianhui, Tian, Ji, Li, Chunhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436423/ https://www.ncbi.nlm.nih.gov/pubmed/37596598 http://dx.doi.org/10.1186/s12951-023-02045-4

Ejemplares similares

WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease
por: Zhang, Qi, et al.
Publicado: (2016)

Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases
por: Wang, Chenglong, et al.
Publicado: (2023)

Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease
por: Vitale, Serena, et al.
Publicado: (2017)

Oxidative Stress Markers in Intestinal Mucosa of Tunisian Inflammatory Bowel Disease Patients
por: Bouzid, Dorra, et al.
Publicado: (2013)

Clinical features of Epstein–Barr virus in the intestinal mucosa and blood of patients with inflammatory bowel disease
por: Zhou, Jin-Qiu, et al.
Publicado: (2020)

Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease
por: Ricanek, Petr, et al.
Publicado: (2015)

Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease
por: Stummer, Nathalie, et al.
Publicado: (2022)

Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study
por: Toskas, Alexandros, et al.
Publicado: (2023)

Systematic Study of Paeonol/Madecassoside Co-Delivery Nanoemulsion Transdermal Delivery System for Enhancing Barrier Repair and Anti-Inflammatory Efficacy
por: Lu, Wangwang, et al.
Publicado: (2023)

Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease
por: Tarris, Georges, et al.
Publicado: (2021)

Nano-modulators with the function of disrupting mitochondrial Ca(2+) homeostasis and photothermal conversion for synergistic breast cancer therapy
por: Wang, Chenglong, et al.
Publicado: (2023)

Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease
por: Chamorro, Nayaret, et al.
Publicado: (2021)

Epstein–Barr Virus and Human Cytomegalovirus Infection in Intestinal Mucosa of Chinese Patients With Inflammatory Bowel Disease
por: Wang, Wei, et al.
Publicado: (2022)

An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease
por: Zhang, Zhuangzhuang, et al.
Publicado: (2023)

Increased GM‐CSF‐producing NCR(‐) ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease
por: Chang, Yuna, et al.
Publicado: (2021)

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?
por: Kruidenier, L, et al.
Publicado: (1998)

Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa
por: Costa, Raquel G.F., et al.
Publicado: (2019)

Oral Delivery of Bioactive Glass‐Loaded Core–Shell Hydrogel Microspheres for Effective Treatment of Inflammatory Bowel Disease
por: Zhu, Yanlun, et al.
Publicado: (2023)

Development and Study of Nanoemulsions and Nanoemulsion-Based Hydrogels for the Encapsulation of Lipophilic Compounds
por: Demisli, Sotiria, et al.
Publicado: (2020)

Intestinal Epithelium in Inflammatory Bowel Disease
por: Coskun, Mehmet
Publicado: (2014)

Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases
por: Rutherford, Duncan, et al.
Publicado: (2023)

Characteristics of Fecal and Mucosa-Associated Microbiota in Chinese Patients With Inflammatory Bowel Disease
por: Chen, Liping, et al.
Publicado: (2014)

Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease
por: Li, Xiaoxiao, et al.
Publicado: (2016)

Dynamic, Transient, and Robust Increase in the Innervation of the Inflamed Mucosa in Inflammatory Bowel Diseases
por: Gonzalez Acera, Miguel, et al.
Publicado: (2021)

Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
por: Dotti, Isabella, et al.
Publicado: (2022)

Antioxidant and anti-inflammatory effects of selenium in oral buccal mucosa and small intestinal mucosa during intestinal ischemia-reperfusion injury
por: Kim, Yongsoo, et al.
Publicado: (2014)

Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin
por: Elsewedy, Heba S., et al.
Publicado: (2022)

Rheological Study of the Formation of Pullulan Hydrogels and Their Use as Carvacrol-Loaded Nanoemulsion Delivery Systems
por: Santamaría, Esther, et al.
Publicado: (2023)

Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy
por: Yoon, Hyo-Jin, et al.
Publicado: (2022)

Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
por: Kim, Jung Mogg
Publicado: (2014)

Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases
por: Kühl, Anja A., et al.
Publicado: (2015)

Extra-Intestinal Manifestations of Inflammatory Bowel Disease
por: Sange, Aliya H, et al.
Publicado: (2021)

Inflammatory bowel disease–associated intestinal fibrosis
por: Park, Ji Min, et al.
Publicado: (2023)

Activation of mTORC1 by LSECtin in macrophages directs intestinal repair in inflammatory bowel disease
por: Li, Qian, et al.
Publicado: (2020)

Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota
por: Munyaka, Peris M., et al.
Publicado: (2016)

Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease
por: Wang, Wenxue, et al.
Publicado: (2022)

Immune and Inflammatory Responses of the Intestinal Mucosa following Extended Liver Radiofrequency Ablation
por: Ypsilantis, Petros, et al.
Publicado: (2017)

Cytomegalovirus Infection in Inflammatory Bowel Disease Is Not Associated with Worsening of Intestinal Inflammatory Activity
por: do Carmo, Alexandre Medeiros, et al.
Publicado: (2014)

Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases
por: Said, Zulfahmi, et al.
Publicado: (2021)

B Lymphocyte intestinal homing in inflammatory bowel disease
por: Defendenti, Caterina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9egdk7pabuscfaaa9393bg2lbv